Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Inventory (2020 - 2025)

Cellebrite DI's Inventory history spans 6 years, with the latest figure at $7.6 million for Q4 2025.

  • Quarterly Inventory fell 14.95% to $7.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.6 million through Dec 2025, down 14.95% year-over-year, with the annual reading at $7.6 million for FY2025, 14.95% down from the prior year.
  • Inventory came in at $7.6 million for Q4 2025, down from $8.6 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $11.4 million in Q1 2023 to a low of $4.8 million in Q3 2021.
  • The 5-year median for Inventory is $9.1 million (2024), against an average of $9.0 million.
  • Year-over-year, Inventory soared 94.47% in 2022 and then fell 18.83% in 2024.
  • Cellebrite DI's Inventory stood at $6.5 million in 2021, then skyrocketed by 56.29% to $10.2 million in 2022, then fell by 2.32% to $9.9 million in 2023, then fell by 10.07% to $8.9 million in 2024, then decreased by 14.95% to $7.6 million in 2025.
  • Per Business Quant, the three most recent readings for CLBT's Inventory are $7.6 million (Q4 2025), $8.6 million (Q3 2025), and $9.5 million (Q2 2025).